Assurance de qualité pour le cancer rectal – phase 2 ...

More documents

Recommendations

Info

94 PROCARE – phase 2 KCE reports 81Quality indicator Subdiscipline(s) Source Ex/inclusion Level Final QI(s)(b) anesthesiologist or equivalentIF a patient who smokes is undergoing colorectal cancer surgery, THENthe patient should be encouraged to stop smoking and the discussiondocumented in the chartIF a patient is undergoing colorectal cancer surgery and has valvular orcongenital heart disease, an intracardiac valvular prosthesis, hypertrophiccardiomyopathy, mitral valve prolapse with regurgitation, or a previousepisode of endocarditis, THEN endocarditis prophylaxis should be givenIF a patient is undergoing colorectal cancer surgery and meets criteria forperioperative beta blockade, THEN unless contraindicated, beta blockertherapy should be initiated before surgeryIF a patient undergoes colorectal cancer surgery and meets criteria forperioperative beta blockade, THEN unless contraindicated, beta blockertherapy should be continued postoperatively at least until discharge fromthe hospitalIF a patient is undergoing colorectal cancer surgery and is taking one ofthe following classes of medications, THEN specific instructions regardingpreoperative management of the following classes of medications shouldbe given to the patient:(a) antiplatelet medications(b) diabetes medications(c) cardiovascular medicationsIF a patient taking warfarin is undergoing colorectal cancer surgery, THENwithdrawal of warfarin before surgery should be managed according torecommendations from the Seventh ACCP Conference onAntithrombotic TherapyIF a patient undergoes colorectal cancer surgery, THEN a nasogastric tubeshould not be used postoperatively, unless the patient has signs/symptomsof obstructionIF a patient undergoes colorectal cancer surgery, THEN the patient's fluidstatus needs to be monitored while the patient is receiving intravenousfluids:(a) daily input and output(b) daily weightsIF a patient with diabetes undergoes colorectal cancer surgery, THENpostoperative blood glucose control should be monitored at least dailyand if >150 then treatment should be initiatedMcGory AspecificMcGory AspecificMcGory AspecificMcGory AspecificMcGory AspecificMcGory AspecificMcGory AspecificMcGory AspecificMcGory Aspecific
KCE Reports 81 PROCARE – phase 2 95Quality indicator Subdiscipline(s) Source Ex/inclusion Level Final QI(s)IF a patient undergoes colorectal cancer surgery, THEN pain assessmentsshould be performed and documented with each set of vital signsIF a patient undergoes colorectal cancer surgery and was able to ambulatepreoperatively, THEN ambulation should be performed within 2 days aftersurgery, or documented why the patient cannot ambulateIF a patient undergoes colorectal cancer surgery and cannot ambulate bypostoperative day 2, THEN mobilization should be performed bypostoperative day 2, or documented why the patient cannot be mobilizedIF a patient undergoes colorectal cancer surgery and is discharged homeand was able to ambulate preoperatively, THEN the patient should be ableto ambulate before discharge OR the reason why the patient is unable toambulate is addressed and a treatment plan outlinedIF a patient undergoes colorectal cancer surgery and has a new fever(greater than 38.5 °C) after postoperative day 2, THEN evaluation of thewound(s) should be documented including erythema, warmth, andpresence of drainageIF a patient undergoes colorectal cancer surgery and has a new fever(greater than 38.5 °C) after postoperative day 2 and there is no obvioussource of infection, THEN the following should be performed within 8 h(unless fever workup completed within the past 24 h):(f) history and physical examination linked to the feverIF a patient undergoes colorectal cancer surgery and has a foley catheterplaced during the operation, THEN the catheter should be removed (ordocumented why not removed) by postoperative day 5IF a patient undergoes colorectal cancer surgery, THEN the patient shouldbe able to tolerate an adequate diet before dischargeIF a patient undergoes colorectal cancer surgery, THEN pain should becontrolled with oral or other nonparenteral medications before dischargeIF a patient has a stage II or III rectal cancer, THEN the patient shouldhave received neoadjuvant chemotherapy or adjuvant chemotherapy witha regimen listed in the associated table or was in a clinical trialIF a patient has stage II or III rectal cancer, THEN the patient shouldreceive radiation therapy either before definitive surgical excision ORafter definitive surgical excisionIF a patient has stage II or III rectal cancer and received radiation therapy,THEN the patient should receive radiation (25 Gy total dose or greater)therapy either before definitive surgical excision OR after definitivesurgical excisionIF a patient has stage II or III rectal cancer, THEN the patient should havea consultation with a radiation oncologistMcGory AspecificMcGory AspecificMcGory AspecificMcGory AspecificMcGory AspecificMcGory AspecificMcGory AspecificMcGory AspecificMcGory AspecificNeoadjuvant, adjuvant NICCQ Inclusion 2 1223, 1241Neoadjuvant, adjuvant NICCQ Inclusion 2 1221, 1222, 1242Neoadjuvant, adjuvant NICCQ Inclusion 2 1221, 1222, 1242General, neoadjuvant, adjuvant NICCQ Inclusion 1,2 1114, 1221, 1222, 1242
Page 1 and 2:
Assurance de qualitépour le cancer
Page 3 and 4:
Assurance de qualité pour lecancer
Page 5 and 6:
KCE Reports 81B Cancer rectal - pha
Page 7:
KCE Reports 81B Cancer rectal - pha
Page 10 and 11:
vi Cancer rectal - phase 2 KCE Repo
Page 12 and 13:
2 PROCARE - phase 2 KCE reports 81A
Page 14 and 15:
4 PROCARE - phase 2 KCE reports 811
Page 16 and 17:
6 PROCARE - phase 2 KCE reports 81F
Page 19 and 20:
KCE Reports 81 PROCARE - phase 2 92
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54: KCE Reports 81 PROCARE - phase 2 43
Page 87 and 88: KCE Reports 81 PROCARE - Phase 2 77
Page 103: KCE Reports 81 PROCARE - phase 2 93
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169:
Page 172 and 173:
Dépôt légal : D/2008/10.273/39
Page 174 and 175:
35. Etude relative aux coûts poten
show all

Assurance de qualité pour le cancer rectal – phase 2 ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?